Literature DB >> 17786368

Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in the U87MG human glioblastoma cell line.

A Papi1, G Bartolini, K Ammar, F Guerra, A M Ferreri, P Rocchi, M Orlandi.   

Abstract

Glioblastomas, the most malignant and prevalent brain tumors which remain incurable, are characterized by both extensive proliferation and invasive growth. We previously reported a remarkable antitumoral effect of the retinoid 6-OH-11-O-hydroxyphenantrene (IIF) on neuroblastoma, leukemia and colon carcinoma cells. In this study we examined the effect of IIF on proliferation, apoptosis and cell invasion in the human glioblastoma cell line U87MG, in comparison with all-trans-retinoic acid (RA). Our results showed that both retinoids induced cell growth inhibition and apoptosis in a dose- and time-dependent manner. We also demonstrated that the invasive ability of glioblastoma cells decreased after treatment with IIF or RA. Since cell invasion involves a complex system of tightly regulated proteases, matrix metalloproteinases (MMPs) and their specific inhibitors, tissue inhibitors of MMPs (TIMPs), we analysed the effect of IIF on MMP and TIMP expression in comparison with RA. Treatment with both retinoids resulted in a marked decrease of MMP2 and MMP9 expression and of lytic activity of MMP2. In addition, exposure to IIF led to enhanced expression of TIMP2. Collectively, our results demonstrated the effectiveness of both IIF and RA in inhibiting proliferation, cell migration, and the invasive potential of glioblastoma U87MG cells. Notably, the anticancer activity of IIF, on the whole, was more pronounced than that of RA. Therefore, these findings, besides providing further evidence that IIF may be a powerful tool in the development of cancer treatments, suggest that IIF may have therapeutic potential against the invasiveness of brain tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786368     DOI: 10.3892/or.18.4.1015

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.

Authors:  Juan Rodrigues; Claudia Abramjuk; Luis Vásquez; Neira Gamboa; José Domínguez; Bianca Nitzsche; Michael Höpfner; Radostina Georgieva; Hans Bäumler; Carsten Stephan; Klaus Jung; Michael Lein; Anja Rabien
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

2.  Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells.

Authors:  A Papi; T Guarnieri; G Storci; D Santini; C Ceccarelli; M Taffurelli; S De Carolis; N Avenia; A Sanguinetti; A Sidoni; M Orlandi; M Bonafé
Journal:  Cell Death Differ       Date:  2012-01-20       Impact factor: 15.828

3.  MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.

Authors:  Fei Wang; Weizhong Xiao; Jiyong Sun; Donghua Han; Youhou Zhu
Journal:  Tumour Biol       Date:  2014-05-28

4.  All-trans retinoic acid inhibits migration, invasion and proliferation, and promotes apoptosis in glioma cells in vitro.

Authors:  Chen Liang; Ling Yang; Shiwen Guo
Journal:  Oncol Lett       Date:  2015-04-15       Impact factor: 2.967

5.  Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma.

Authors:  Jin Chen; Qin Huang; Feng Wang
Journal:  Tumour Biol       Date:  2014-04-27

6.  Identification of rare cancer driver mutations by network reconstruction.

Authors:  Ali Torkamani; Nicholas J Schork
Journal:  Genome Res       Date:  2009-07-02       Impact factor: 9.043

7.  Inhibitory effects of retinoic acid on invasiveness of human thyroid carcinoma cell lines in vitro.

Authors:  L Lan; D Cui; Y Luo; B Y Shi; L L Deng; G Y Zhang; H Wang
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

Review 8.  Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair.

Authors:  Suya Wang; Jianshi Yu; Maureen A Kane; Alexander R Moise
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

9.  Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor beta.

Authors:  Marina Ines Flamini; Gisel Valeria Gauna; Mayra Lis Sottile; Beatriz Silvina Nadin; Angel Matias Sanchez; Laura Maria Vargas-Roig
Journal:  J Cell Mol Med       Date:  2014-04-10       Impact factor: 5.310

10.  All-Trans Retinoic Acid Enhances Matrix Metalloproteinase 2 Expression and Secretion in Human Myeloid Leukemia THP-1 Cells.

Authors:  Hien Thi Vu; Thi Xoan Hoang; Jae Young Kim
Journal:  Biomed Res Int       Date:  2018-08-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.